Park Ha Biological Technology Co., Ltd.
corporate_fare Company Profile
Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for BYAH at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Park Ha Biological Reports $24.36M Net Loss, Cites Massive Share-Based Compensation & Internal Control Weakness
- Amended Annual Report Reveals $24.36M Loss, Ineffective Internal Controls, and Significant Franchisee Decline
- Micro-Cap Biotech Files $300M Universal Shelf Registration, Enabling Significant Future Dilution
- Park Ha Biological Technology Regains Nasdaq Compliance, Averting Delisting Risk
- Annual Report Reveals Massive Net Loss, Highly Dilutive Offering, and Critical Internal Control Weakness
Financial Snapshot
Insider Transactions
BYAH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.